---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-275897"
form_type: "8-K"
ticker: "SRPT"
cik: "0000873303"
company_name: "Sarepta Therapeutics, Inc."
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T16:20:59.491347+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sarepta EVP Technical Ops resigns, Bilal Arif appointed as replacement

## Summary
- William F. Ciambrone to resign as EVP Technical Operations effective Dec 31, 2022.
- Ciambrone to consult through Q2 2023 at $500/hour; equity continues vesting.
- Board appointed Bilal Arif as Chief Technical Operations Officer effective Dec 31, 2022.
- Resignation not due to any disagreement with company operations or policies.
- Ciambrone will receive 2022 annual bonus and COBRA coverage through consulting period.

## SEC filing metadata
- accession: 0001193125-22-275897
- form_type: 8-K
- ticker: SRPT
- cik: 0000873303
- company_name: Sarepta Therapeutics, Inc.
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/d393292d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-275897
- JSON: https://secwatch.observer/filing/0001193125-22-275897.json
- Plain text: https://secwatch.observer/filing/0001193125-22-275897.txt

## Key facts
- Executive change
  Bilal Arif was appointed as Chief Technical Operations Officer at Sarepta Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Technical Operations Officer
  source text: On October 31, 2022, the Board appointed Bilal Arif, the Company’s Senior Vice President, Strategy and Operations, as the Company’s Chief Technical Operations Officer, effective as of December 31, 2022 and upon Mr. Ciambrone’s retirement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm
- Executive change
  William F. Ciambrone resigned as Executive Vice President, Technical Operations at Sarepta Therapeutics, Inc..
  - Action: resigned
  - Role: Executive Vice President, Technical Operations
  source text: On October 31, 2022, William F. Ciambrone informed Sarepta Therapeutics, Inc. (the “Company”) of his resignation from his position as the Company’s Executive Vice President, Technical Operations, effective as of December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/873303/000119312522275897/0001193125-22-275897-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.